Literature DB >> 24952033

Abdominal aortic and junctional tourniquet controls hemorrhage from a gunshot wound of the left groin.

John Croushorn.   

Abstract

"Junctional hemorrhage" is defined as bleeding from the areas at the junction of the trunk and its appendages. This is an important cause of potentially preventable deaths on the battlefield and a difficult condition to treat in the civilian prehospital setting. Having a solution to definitively treat the condition decreases the mortality and morbidity of these injuries. The Abdominal Aortic and Junctional Tourniquet(tm) is (1) a Food and Drug Administration?cleared device that is currently indicated for pelvic, inguinal, and axillary bleeding; (2) the only junctional tourniquet with an indication for pelvic bleeding; (3) the only junctional tourniquet reported with a successful axillary use; and (4) effective at lower tissue pressures than other junctional tourniquets available. 2014.

Entities:  

Mesh:

Year:  2014        PMID: 24952033     DOI: 10.55460/8IYL-YPCC

Source DB:  PubMed          Journal:  J Spec Oper Med        ISSN: 1553-9768


  3 in total

1.  The effectiveness of portable ultrasound-guided resuscitative endovascular balloon occlusion of the aorta for stopping iliac artery hemorrhage during first aid pre-hospital: a randomized control animal trial.

Authors:  Yuqing Huang; Haiyan Kou; Yuhao Kong; Xuexia Shan; Shengzheng Wu; Xianghui Chen; Xingxi Lin; Liye Zhang; Faqin Lv; Zhihui Li
Journal:  Eur J Trauma Emerg Surg       Date:  2022-04-12       Impact factor: 2.374

Review 2.  A review of two emerging technologies for pre-hospital treatment of non-compressible abdominal hemorrhage.

Authors:  Brendan M McCracken; Kevin R Ward; Mohamad Hakam Tiba
Journal:  Transfusion       Date:  2022-06-24       Impact factor: 3.337

Review 3.  Prehospital control of life-threatening truncal and junctional haemorrhage is the ultimate challenge in optimizing trauma care; a review of treatment options and their applicability in the civilian trauma setting.

Authors:  S E van Oostendorp; E C T H Tan; L M G Geeraedts
Journal:  Scand J Trauma Resusc Emerg Med       Date:  2016-09-13       Impact factor: 2.953

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.